Intercept Pharma (ICPT) Tops Q1 EPS by 20c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CRWD
5. CHKP
6. ON
7. HNGE
8. INSP
9. SPY
10. MRVL

Go back to Intercept Pharma (ICPT) Tops Q1 EPS by 20c

Intercept Pharmaceuticals Announces First Quarter 2018 Financial Results, Issues 2018 Ocaliva Net Sales Guidance and Provides Business Update

May 8, 2018 7:05 AM EDT

Worldwide Ocaliva net sales of $35.2 million in the first quarter of 20182018 worldwide Ocaliva net sales currently expected to be between $170 million and $185 millionContinuing to advance leading NASH Phase 3 program: REGENERATE trial in non-cirrhotic NASH patients with liver fibrosis on track to report data in the first half of 2019; REVERSE trial in NASH patients with compensated cirrhosis continues to enroll patientsConference call scheduled for 8:30 a.m. ET today

NEW YORK, May 08, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc.... More